We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reneuron Group Plc | LSE:RENE | London | Ordinary Share | GB00BF5G6K95 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.05 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 530k | -5.41M | -0.0946 | -0.32 | 1.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/5/2019 08:25 | Because the company reports on an annual basis it is saying no fund raising required in the next 12 months. | esmerelda | |
08/5/2019 08:17 | Bought a few more at 284p | volsung | |
08/5/2019 08:15 | The cash burn last year was £11m and funds in hand £26m now, so why just 12mths? | rayrac | |
08/5/2019 08:11 | Agreed ... reassuring to hear that the cash will sustain them. Negotiations on going. | chrisis33 | |
08/5/2019 08:05 | Great Update.. New deals under negotiation... Cash in Bank for next 12 Months confirmed.. Great News all round....GLA! | daffodil4 | |
08/5/2019 08:05 | Also cash likely to last 12 months, surely not, what's the cash burn | milliecusto | |
08/5/2019 08:04 | Results due to the latter half of 2020 now, yeah i'll I think my 240 is nailed on | milliecusto | |
08/5/2019 07:32 | Get ready for new partners/new agreements/new financial arrangements? We shall see! | rayrac | |
07/5/2019 20:15 | Yeah 240 you said good luck haha trolls about today ... news soon as is 6 quid | eggy6198 | |
07/5/2019 17:11 | So I was right, recent volume insufficient to breach 52 wk high, short term will see a retrace now | milliecusto | |
07/5/2019 16:15 | ...seems to be mainly regarding regulatory challenges and opportunities... | sja123 | |
07/5/2019 16:13 | .....so they are! Wednesday 8th May 2019 3:30 pm Regulatory Challenges and Opportunities for Allogeneic Cell Therapies: Theory and Real World Experiences Shaun Stapleton Head of Regulatory Affairs , ReNeuron Synopsis Regulatory control of allogenic cell therapies – global similarities and differences Key regulatory challenges facing allogeneic cell therapies – CMC, nonclinical and clinical aspects Opportunities for expedited development and approval – global regulatory programmes and standards | sja123 | |
07/5/2019 15:55 | ReNeuron are presenting at the Allogeneic Cell Therapies Summit Boston USA 7-9th May 2019. | daffodil4 | |
07/5/2019 12:21 | If there is one share that should be on the end of profit-taking in a bad market like today's, then RENE should be it. Instead it's actually up as I write. That's very impressive. | dickbush | |
07/5/2019 11:41 | Totally next results will be critcal but we are running at 100% if that works again at 100% well stats suggest we are going to get to.product which means billions and a 10% to 30% rise wont cut it. Will need to be x5 + to be fair reflection | eggy6198 | |
07/5/2019 10:31 | We shall see eggy...just got to see what the next results bring forth? But I take a great deal of reassurance from the Chinese deal...that’s about all we can do?...until the results! It’s up in the air till then. | rayrac | |
07/5/2019 10:19 | Thats why they do it to try and get people locked to losses on another share. Its just spam. I still feel this share should run upto 6 on where we are now hence mot movinga penny and will invest more on next positive update. If spark is worth 40× this with one much poorer product we are talking multi billion company here with no need for funding as deals will fund company | eggy6198 | |
07/5/2019 09:53 | Agreed... It is actually a sign of desperation to repeatedly plug a share on another board.... RENE has a new platform to move forward from.. Partner on Board and very strong update... do not think it will be under £4 much longer.. GLA! | daffodil4 | |
07/5/2019 09:20 | Toople may be the best thing since fried bread, but it is very frustrating when I keep getting alerts on the Reneuron board about a completely different company. There are probably many companies that 'could' give a better rate of return than Reneuron, each with there associated risk. I think every investor on here is aware of that and is able to do their own research and come to their own decisions. The point of this board is about research into Reneuron. If I want to research Toople, I will look at a Toople board. So please, KEEP ON TOPIC. | masingi | |
07/5/2019 09:08 | Possible 150 bagger | eggy6198 | |
07/5/2019 08:07 | Look at least toop is going up to, easier to double your money there quicker, whatever stock you're in good luck | milliecusto | |
07/5/2019 08:05 | tt is probably right about Toop being a possible 150x bagger from here but you obviously only want to own one share. | tewkesbury | |
07/5/2019 06:32 | I dont care just stop posting about toople tiny telco that needs money unless and this is key its the toople board! | eggy6198 | |
07/5/2019 00:12 | I still think Rene might be £7 if all goes well and said so several times and bought when they were still in the 50's. | top tips | |
06/5/2019 23:53 | Eggy, I held Reneuron during the recent rise and posted several times on it merits.Just assumed people would be interested to hear about Toople now, as their upside going forward looks much bigger than for Reneuron's and lower risk.Through spreading such information we help one another. | top tips |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions